Consolidated Statements of Changes in Stockholders' Deficit - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2021	$ (2,816)	$ 1	$ 73,495	$ (76,312)
Beginning Balances (in shares) at Dec. 31, 2021		7,238,767
Conversion of notes payable to common shares	5,989		5,989
Stock issued during period, Shares		700,000
PIPE financing, net of liability classified PIPE warrants	5,744		5,744
Issuance of liability classified warrants	(10,194)		(10,194)
Issuance of shares - conversion of convertible notes, Shares		598,861
Forward purchase agreement prepayment	(11,900)		(11,900)
Stock-based compensation	1,311		1,311
Net loss	(12,190)			(12,190)
Ending Balance at Dec. 31, 2022	(20,762)	$ 1	67,739	(88,502)
Ending Balances (in shares) at Dec. 31, 2022		12,699,668
Issuance of shares - equity line of credit, Shares		378,006
Issuance of shares - equity line of credit	1,108		1,108
Issuance of shares - commitment fee for equity line of credit, Shares		218,842
Issuance of shares - commitment fee for equity line of credit	1,000		1,000
Issuance of shares - prepaid forward contracts	1,870		1,870
Stock-based compensation	505		505
Net loss	(7,096)			(7,096)
Ending Balance at Mar. 31, 2023	(23,375)	$ 1	72,222	(95,598)
Ending Balances (in shares) at Mar. 31, 2023		13,296,516
Beginning Balance at Dec. 31, 2022	(20,762)	$ 1	67,739	(88,502)
Beginning Balances (in shares) at Dec. 31, 2022		12,699,668
Issuance of shares - equity line of credit, Shares		6,500,000
Issuance of shares - equity line of credit	4,742	$ 1	4,741
Issuance of shares - commitment fee for equity line of credit, Shares		218,842
Issuance of shares - commitment fee for equity line of credit	1,000		1,000
Issuance of shares - conversion of convertible notes, Shares		22,847,745
Issuance of shares - conversion of convertible notes	10,411	$ 2	10,409
Issuance of shares - exercise of warrants, Shares		2,955,164
Issuance of shares - exercise of warrants	1,652	$ 1	1,651
Issuance of shares - vesting of RSU's, Shares		205,947
Issuance of shares - prepaid forward contracts, Shares		1,096,972
Issuance of shares - prepaid forward contracts	1,870		1,870
Forward purchase agreement derivative liability	11,519		11,519
Stock-based compensation, Shares		1,090,947
Stock-based compensation	1,930		1,930
Net loss	(26,232)			(26,232)
Ending Balance at Dec. 31, 2023	(13,870)	$ 5	100,859	(114,734)
Ending Balances (in shares) at Dec. 31, 2023		47,615,285
Beginning Balance at Mar. 31, 2023	(23,375)	$ 1	72,222	(95,598)
Beginning Balances (in shares) at Mar. 31, 2023		13,296,516
Issuance of shares - equity line of credit, Shares		26,996
Issuance of shares - equity line of credit	55		55
Issuance of shares - conversion of convertible notes, Shares		3,088,167
Issuance of shares - conversion of convertible notes	1,937	$ 1	1,936
Issuance of shares - vesting of RSU's, Shares		153,405
Issuance of shares - prepaid forward contracts, Shares		1,096,972
Issuance of shares - prepaid forward contracts	0		0
Stock-based compensation, Shares		459,185
Stock-based compensation	555		555
Net loss	(2,447)			(2,447)
Ending Balance at Jun. 30, 2023	(11,756)	$ 2	86,287	(98,045)
Ending Balances (in shares) at Jun. 30, 2023		18,121,241
Issuance of shares - equity line of credit, Shares		234,579
Issuance of shares - equity line of credit	120		120
Issuance of shares - conversion of convertible notes, Shares		8,432,517
Issuance of shares - conversion of convertible notes	2,411	$ 1	2,410
Issuance of shares - vesting of RSU's, Shares		32,839
Stock-based compensation, Shares		379,914
Stock-based compensation	440		440
Net loss	(7,232)			(7,232)
Ending Balance at Sep. 30, 2023	$ (16,017)	$ 3	$ 89,257	$ (105,277)
Ending Balances (in shares) at Sep. 30, 2023		27,201,090